Healthcare provider profile · identity verified

Rhett Miller

Internal Medicine · WASHINGTON, IL · NPI 1871675645

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	597	170
Lisinopril	Lisinopril	421	122
Omeprazole	Omeprazole	324	89
Levothyroxine Sodium	Levothyroxine Sodium	316	88
Amlodipine Besylate	Amlodipine Besylate	297	84
Simvastatin	Simvastatin	288	76
Tamsulosin Hcl	Tamsulosin Hcl	288	82
Pravastatin Sodium	Pravastatin Sodium	233	63
Losartan Potassium	Losartan Potassium	229	67
Metformin Hcl	Metformin Hcl	216	64
Gabapentin	Gabapentin	208	58
Fluoxetine Hcl	Fluoxetine Hcl	181	50
Hydrochlorothiazide	Hydrochlorothiazide	177	57
Metoprolol Succinate	Metoprolol Succinate	147	44
Famotidine	Famotidine	134	38
Alprazolam	Alprazolam	129	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	129	41
Sertraline Hcl	Sertraline Hcl	124	34
Furosemide	Furosemide	122	39
Valsartan	Valsartan	121	34
Escitalopram Oxalate	Escitalopram Oxalate	117	34
Tramadol Hcl	Tramadol Hcl	116	32
Zolpidem Tartrate	Zolpidem Tartrate	114	20
Albuterol Sulfate Hfa	Albuterol Sulfate	105	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	103	25
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	100	31
Rosuvastatin Calcium	Rosuvastatin Calcium	93	21
Trazodone Hcl	Trazodone Hcl	90	27
Duloxetine Hcl	Duloxetine Hcl	88	22
Pantoprazole Sodium	Pantoprazole Sodium	86	26
Celecoxib	Celecoxib	85	28
Eliquis	Apixaban	85	18
Warfarin Sodium	Warfarin Sodium	83	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	82	32
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	82	26
Prednisone	Prednisone	76	61
Lorazepam	Lorazepam	73	16
Clopidogrel	Clopidogrel Bisulfate	71	21
Spironolactone	Spironolactone	71	14
Meloxicam	Meloxicam	70	22
Montelukast Sodium	Montelukast Sodium	69	22
Fenofibrate	Fenofibrate	65	19
Atenolol	Atenolol	64	17
Fluticasone Propionate	Fluticasone Propionate	64	24
Naproxen	Naproxen	64	41
Allopurinol	Allopurinol	63	17
Glimepiride	Glimepiride	63	15
Metoprolol Tartrate	Metoprolol Tartrate	60	18
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	60	16
Jardiance	Empagliflozin	58	13
Clonazepam	Clonazepam	52	suppressed
Glipizide Er	Glipizide	51	19
Alendronate Sodium	Alendronate Sodium	48	15
Glipizide	Glipizide	48	14
Venlafaxine Hcl Er	Venlafaxine Hcl	48	13
Carvedilol	Carvedilol	47	14
Triamcinolone Acetonide	Triamcinolone Acetonide	46	21
Potassium Chloride	Potassium Chloride	43	15
Lovastatin	Lovastatin	40	11
Januvia	Sitagliptin Phosphate	38	suppressed
Bupropion Xl	Bupropion Hcl	37	12
Hydroxyzine Hcl	Hydroxyzine Hcl	37	13
Pregabalin	Pregabalin	36	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	32	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	32	12
Diclofenac Sodium	Diclofenac Sodium	32	14
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Fentanyl	Fentanyl	29	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Ondansetron Odt	Ondansetron	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	23
Cephalexin	Cephalexin	24	22
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Mupirocin	Mupirocin	23	17
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Carisoprodol	Carisoprodol	22	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Diazepam	Diazepam	22	suppressed
Finasteride	Finasteride	22	suppressed
Irbesartan	Irbesartan	22	suppressed
Metformin Hcl Er	Metformin Hcl	22	suppressed
Ketoconazole	Ketoconazole	21	17
Hydrocortisone	Hydrocortisone	20	13
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	19	suppressed
Amoxicillin	Amoxicillin	18	13
Propranolol Hcl	Propranolol Hcl	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Glyburide	Glyburide	15	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Nabumetone	Nabumetone	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Dutasteride	Dutasteride	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Baclofen	Baclofen	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	13
Clindamycin Hcl	Clindamycin Hcl	13	12
Dilt-Xr	Diltiazem Hcl	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Hydrocodone-Ibuprofen	Hydrocodone/Ibuprofen	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Azithromycin	Azithromycin	11	11
Cilostazol	Cilostazol	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Indomethacin	Indomethacin	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Topiramate	Topiramate	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed
Zenpep	Lipase/Protease/Amylase	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error